Page 734 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 734

692                                         AUTRES ANTTTUMORAUX

             MGBCP
              MORI K. et al., Effects of methylglyoxal bis(cyclopentylamidinohydrazone) (MGBCP) on
               cell cycle progression in three human osteosarcoma cell lines, AnticancerRes., 1996,
               16, 2565-2567.
              KANEKO H. et al., Apoptosis induction in breats cancer MRK-nu-1 cells by a polyamine
               synthesis inhibitor, methylglyoxal bis(cyclopentylamidinohydrazone) (MGBCP), Anti-
               cancer Res., 1998, 18, 891-896.
              KANEKO H. et al., lnvolvment of apoptosis and cyclin D1 gene repression in growth
                inhibition of T-47D human breast cancer celis by methylglyoxal bis(cyclopentylamidi-
                nohydrazone), /nt. J. Mol. Med., 1998, 1, 931-936.
              HASHIMOTO Y. et al., Induction of apoptotic cell death in human hepaticellular carci-
                noma SK-HEP-1 cells by a polyamine synthesis inhibitor, methylglyoxal bis(cyclopen-
                tylamidionhydrazone), Anticancer drugs, 1999, 10, 323-327.
              SATOH N. et al., Growth inhibition of human osteosarcoma HUO9 cells by methylglyoxal
                bis(cyclopentylamidinohydrazone) in vitro et in vivo, Onco/. Rep., 1999, 9, 627-630.
              WAKABAYASHI H. et al., Prevention of metastasis by a polyamine synthesis inhibitor in
                an animal bone metastasis model, Oncology, 2000, 59, 75-80.
              Dérivés de la 1,3-diazépine
              KREZEL I., GRACZYK J., Synthesis and preliminary antileukemic studies of cyclic ana-
                logs, // Farmaco, 1998, 53, 244-247.
              CGP 39937 et 33829
              THOMAS T. et al., Structure activity relations of S-adenosylmethionine decarboxylase
                inhibitors on the growth of MCF-7 breast cancercells, Breast CancerRes. treat., 1996,
                39, 293-306.
               Dérivés des polyamines
               CASERO R. A. Jr, WOSTER P. M., Terminally alkylated polyamine analogues as chemo-
                therapeutic agents, J. Med. Chem., 2001, 44, 1-26.
                                                         1
                                                           14
               VALASINAS A. et al., Conformationnaly restricted analogues of N, N-bisethylhomos-
                 permine (BE-4-4-4): synthesis and growth inhibitory affects on human prostate can-
                 cer cells., J. Med. Chem., 2001, 44, 390-403.
               REDDY V.K. et al., Cis-unsaturated analogues of 3,8,13,18,13,23-pentaazapentacosane
                 (BE-4-4-4-4-4) :synthesis and growth inhibitory effects on human prostate cancer cell
                 lines, J. Med. Chem., 2001, 44, 404-417.
               BERGERON R.J. et al., Synthesis and evaluation of hydroxylated polyamine analogues
                 as antiproliferatives, J. Med. Chem. 2001, 44, 2451-2459.
               CHEN Y. et al., Apoptic signaling in polyamine-treated SK-MEL-28 human melanoma
                 cells, Cancer Research, 2001, 61, 6437-6444
               Éflomithine
               Eflornithine, Drugs. Fut., 2001, 26, 291-293.
   729   730   731   732   733   734   735   736   737   738   739